PETS — PETMED EXPRESS INC
—
Nasdaq ·
Consumer Staples ·
Drug Retail ·
CIK 1040130 ·
Last close
$0.90
Market Cap
$20.00M
52W High
$4.10
52W Low
$0.85
ADV30
125,090
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 35,770,000 | 9,803,000 | -6,419,000 | -6,434,000 | 59,403,000 | 11,418,000 | 42,541,000 |
| Jun 2026 | 41,015,000 | 11,333,000 | -6,232,000 | -6,145,000 | 63,762,000 | 13,079,000 | 40,773,000 |
| Mar 2026 | 42,817,000 | 13,942,000 | -5,692,000 | -4,061,000 | 81,191,000 | 21,412,000 | 52,251,000 |
| Dec 2025 | 40,660,000 | 9,456,000 | -10,469,000 | -10,553,000 | 87,965,000 | 26,914,000 | 55,199,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-22,693,000
Investing CF
$-1,926,000
Financing CF
$-61,000
CapEx
$-4,571,000
Dividends Paid
$2,000
Buybacks
—
EPS Diluted TTM
$-1.28
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-3,316,000
Inventory
$6,303,000
Receivables
$1,373,000
ST Investments
—
EBIT TTM
$-28,812,000
Pretax Income TTM
$-27,257,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$160,262,000
EBITDA
$-16,628,000
Free Cash Flow
$-12,224,625
Enterprise Value
$9,690,044
Total Cash
$11,418,000
Total Debt
$291,000
Shares Out
22,231,281
Trailing EPS
$-1.29
Book Value
$0.76
ROE
-90.8%
ROA
-20.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 179,021,000 | -31,415,000 | -57,286,000 | 81,191,000 | 52,251,000 | 28,940,000 | -28,394,000 |
| Mar 2025 | — | — | — | — | — | — | — |
| Mar 2024 | 274,095,000 | -8,162,000 | -7,464,000 | 169,884,000 | 73,153,000 | 96,731,000 | 4,317,000 |
| Mar 2023 | 247,569,000 | 6,051,000 | 5,140,000 | 167,478,000 | 57,512,000 | 109,966,000 | 27,803,000 |
| Mar 2022 | 272,282,000 | 24,290,000 | 18,716,000 | 179,698,000 | 56,248,000 | 123,450,000 | 18,498,000 |
TTM Snapshot
Revenues TTM
$168,856,000
NetIncome TTM
$-29,279,000
OpCashFlow TTM
—
Assets (Latest)
$63,762,000
Forward EPS
$-0.03
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| YI | 111, Inc. | $14.39M | $2.77 | — |
| RDGT | Ridgetech Inc. | $3.74M | $1.03 | — |
| GRDN | Guardian Pharmacy Services, Inc. | $3.19B | $50.33 | — |
| CVS | CVS HEALTH Corp | $109.79B | $85.81 | — |
| CANN | TREES Corp (Colorado) | — | $nan | — |
News headlines (Yahoo Finance, 1h cache)
PetMed Express Inc (PETS) (Q2 2027) Earnings Call Highlights: New CEO Charts Multiyear ...
2026-11-11 09:06 · Yahoo
PetMed: Fiscal Q2 Earnings Snapshot
2026-11-10 21:44 · Yahoo
PetMeds® Announces Second Quarter Financial Results
2026-11-10 21:05 · Yahoo
PetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital Channels
2026-11-09 21:05 · Yahoo
PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026
2026-10-27 20:15 · Yahoo
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-02 20:05 · Yahoo
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
2026-09-21 12:30 · Yahoo
PetMed Express (PETS) Q1 2027 Earnings Call Transcript
2026-08-20 22:58 · Yahoo
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y
2026-08-14 15:33 · Yahoo
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Narrowing Losses and Strategic ...
2026-08-14 05:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.